Ardelyx Inc (NASDAQ: ARDX) on Friday, plunged -4.09% from the previous trading day, before settling in for the closing price of $5.14. Within the past 52 weeks, ARDX’s price has moved between $4.32 and $9.33.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 159.99%. The company achieved an average annual earnings per share of -37.14%. With a float of $230.57 million, this company’s outstanding shares have now reached $238.02 million.
Let’s determine the extent of company efficiency that accounts for 395 employees. In terms of profitability, gross margin is 84.55%, operating margin of -8.38%, and the pretax margin is -11.65%.
Ardelyx Inc (ARDX) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ardelyx Inc is 3.27%, while institutional ownership is 63.54%. The most recent insider transaction that took place on Mar 17 ’25, was worth 242,559. Before that another transaction happened on Mar 07 ’25, when Company’s President & CEO sold 41,668 for $5.36, making the entire transaction worth $223,199. This insider now owns 1,635,138 shares in total.
Ardelyx Inc (ARDX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -37.14% per share during the next fiscal year.
Ardelyx Inc (NASDAQ: ARDX) Trading Performance Indicators
Ardelyx Inc (ARDX) is currently performing well based on its current performance indicators. A quick ratio of 4.31 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.17, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach 0.25 in one year’s time.
Technical Analysis of Ardelyx Inc (ARDX)
Looking closely at Ardelyx Inc (NASDAQ: ARDX), its last 5-days average volume was 5.01 million, which is a jump from its year-to-date volume of 4.15 million. As of the previous 9 days, the stock’s Stochastic %D was 16.33%. Additionally, its Average True Range was 0.29.
During the past 100 days, Ardelyx Inc’s (ARDX) raw stochastic average was set at 27.35%, which indicates a significant increase from 2.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.98% in the past 14 days, which was lower than the 79.57% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.39, while its 200-day Moving Average is $5.66. However, in the short run, Ardelyx Inc’s stock first resistance to watch stands at $5.08. Second resistance stands at $5.22. The third major resistance level sits at $5.31. If the price goes on to break the first support level at $4.85, it is likely to go to the next support level at $4.76. Should the price break the second support level, the third support level stands at $4.62.
Ardelyx Inc (NASDAQ: ARDX) Key Stats
Market capitalization of the company is 1.18 billion based on 238,356K outstanding shares. Right now, sales total 333,620 K and income totals -39,140 K. The company made 116,130 K in profit during its latest quarter, and 4,640 K in sales during its previous quarter.
